Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSealand Cap Regulatory News (SCGL)

  • This share is currently suspended. It was suspended at a price of 0.25

Share Price Information for Sealand Cap (SCGL)

Share Price is delayed by 15 minutes
Get Live Data
0.25    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £16.37m
SCGL Live PriceLast checked at - London Stock Exchange

Intraday Sealand Cap Share Chart

Directorate Change

27 Nov 2017 10:13

RNS Number : 5908X
Sealand Capital Galaxy Limited
27 November 2017
 

27 November 2017

Sealand Capital Galaxy Limited (LSE: SCGL)

("Sealand" or the "Company")

Director Appointment

Sealand is pleased to announce that Frazer McRae has been appointed as a Non-Executive Director of the Company on 24 November

Mr McRae comes from a background in Investment Banking and Foreign Exchange, having worked for Morgan Stanley, Deutsche Bank and Merrill Lynch in both London and Hong Kong.

Mr McRae has particular skills and experience in building businesses in the fintech area generally and cross-border payment and blockchain specifically. These skills and experience are expected to be particularly relevant to Sealand as it develops its cooperation with WechatPay in the future.

Mr McRae is CEO of Y2P technologies which is a co-signatory to Sealand's WechatPay Agency Agreement that was announced on 8 September 2017.

Mr Nelson Law, Executive Chairman of Sealand, commented:

"We are delighted to have secured the services of Frazer as Non-Executive Director. Sealand is particularly focussed on building its cooperation with Wechat and his skills and experience will be central to achieving success in this".

 Enquiries:

 Sealand Capital Galaxy

Nicholas Lyth, Non-Executive Director 07769 906 686

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAFEFFSWFWSEFF
Date   Source Headline
30th Apr 20267:00 amRNSAssignment of CLN Investment in EVOO AI plc
29th Apr 20267:48 amRNSTemporary Suspension
30th Mar 202611:50 amRNSDirector/PDMR Shareholding
30th Mar 202611:38 amRNSCLN Conversion, Exercise of Warrants & TVR
26th Mar 202611:48 amRNSResult of General Meeting
16th Mar 20269:19 amRNSDirector/PDMR Shareholding
16th Mar 20269:19 amRNSDirector/PDMR Shareholding
11th Mar 202611:10 amRNSIssue of Equity
6th Mar 20264:54 pmRNSNotice of General Meeting
17th Feb 20267:00 amRNSAppointment of Financial Adviser
27th Jan 20264:00 pmRNSStrategic Update and Business Expansion
21st Jan 20264:00 pmRNSDirector Appointment and CFO Appointment
6th Jan 202612:43 pmRNSStatement re Share Price Movement
8th Dec 20253:00 pmRNSDirector Appointment
7th Nov 202512:05 pmRNSPublication of a Prospectus
30th Sep 20251:30 pmRNSHalf-year Report
22nd May 202510:22 amRNSExercise of Warrants
30th Apr 20255:00 pmRNSResults of General Meetings of Warrant Holders
30th Apr 20254:55 pmRNSFinal Results for the Year Ended 31 December 2024
25th Apr 20254:11 pmRNSNotice of General Meetings of Warrant Holders
14th Mar 20257:00 amRNS-REVOO AI PLC Appoints Gordon Radley as New Director
6th Mar 20257:00 amRNS-REVOO’s acceptance into the NVIDIA Connect Program
28th Feb 20254:33 pmRNS-RCEO Interviewed by StockBox Media
28th Feb 20257:00 amRNSTotal Voting Rights
26th Feb 20257:00 amRNSSelection of Strategic Development Partner
24th Feb 20257:00 amRNS-RCorporate Update - Strategic Growth Initiatives
31st Jan 20254:32 pmRNSExercise of Convertible Loan Note and TVR
27th Jan 20257:00 amRNSFormation of ‘SEA-VOO AI ASIA’
20th Jan 20259:17 amRNSAppointment of Chief Executive Officer
10th Jan 20252:50 pmRNSAGM RESULTS AND INVESTMENT IN EVOO AI PLC
6th Jan 20253:24 pmRNSStatement re Share Price Movement
30th Dec 20247:00 amRNSConditional Issue of Equity and Issue of CLN
16th Dec 20247:00 amRNSNotice of AGM
4th Dec 20242:07 pmRNSShare Price Movement
22nd Nov 202410:08 amRNSConditional Investment Agreement
30th Sep 20247:00 amRNSInterim Results
11th Sep 20247:00 amRNSIssue of Equity
30th Apr 202412:30 pmRNSFinal Results
29th Jan 20247:00 amRNSIssue of Equity
29th Sep 20237:00 amRNSUnaudited Interim Results
16th Jun 20237:00 amRNSLifting of suspension, recommencement of trading
6th Jun 202310:11 amRNSREPLACEMENT: MOU WITH PARTNER IN GREATER CHINA
6th Jun 20239:13 amRNSMOU SIGNED WITH PARTNER IN GREATER CHINA
5th Jun 20233:02 pmRNSFinal results for the year ended 31 December 2022
2nd May 20237:57 amRNSDELAY IN PUBLISHING AUDITED FINANCIAL STATEMENTS
17th Apr 20237:00 amRNSHH Simonsen distributorship agreement update
30th Dec 20227:00 amRNSTotal Voting Rights
21st Dec 20227:00 amRNSIssue of Equity
27th Sep 20227:00 amRNSUnaudited Interim Results
30th Jun 20227:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.